Table of Contents Executive Summary 1 Industry Overview of Meningococcal Disease Drugs 1.1 Definition of Meningococcal Disease Drugs 1.2 Meningococcal Disease Drugs Segment by Type 1.2.1 Global Meningococcal Disease Drugs Production Growth Rate Comparison by Types (2014-2025) 1.2.2 Injectable 1.2.3 Oral 1.3 Meningococcal Disease Drugs Segment by Applications 1.3.1 Global Meningococcal Disease Drugs Consumption Comparison by Applications (2014-2025) 1.3.2 Hospitals 1.3.3 Drugstores 1.3.4 Others 1.4 Global Meningococcal Disease Drugs Overall Market 1.4.1 Global Meningococcal Disease Drugs Revenue (2014-2025) 1.4.2 Global Meningococcal Disease Drugs Production (2014-2025) 1.4.3 North America Meningococcal Disease Drugs Status and Prospect (2014-2025) 1.4.4 Europe Meningococcal Disease Drugs Status and Prospect (2014-2025) 1.4.5 China Meningococcal Disease Drugs Status and Prospect (2014-2025) 1.4.6 Japan Meningococcal Disease Drugs Status and Prospect (2014-2025) 1.4.7 Southeast Asia Meningococcal Disease Drugs Status and Prospect (2014-2025) 1.4.8 India Meningococcal Disease Drugs Status and Prospect (2014-2025) 2 Manufacturing Cost Structure Analysis 2.1 Raw Material and Suppliers 2.2 Manufacturing Cost Structure Analysis of Meningococcal Disease Drugs 2.3 Manufacturing Process Analysis of Meningococcal Disease Drugs 2.4 Industry Chain Structure of Meningococcal Disease Drugs 3 Development and Manufacturing Plants Analysis of Meningococcal Disease Drugs 3.1 Capacity and Commercial Production Date 3.2 Global Meningococcal Disease Drugs Manufacturing Plants Distribution 3.3 Major Manufacturers Technology Source and Market Position of Meningococcal Disease Drugs 3.4 Recent Development and Expansion Plans 4 Key Figures of Major Manufacturers 4.1 Meningococcal Disease Drugs Production and Capacity Analysis 4.2 Meningococcal Disease Drugs Revenue Analysis 4.3 Meningococcal Disease Drugs Price Analysis 4.4 Market Concentration Degree 5 Meningococcal Disease Drugs Regional Market Analysis 5.1 Meningococcal Disease Drugs Production by Regions 5.1.1 Global Meningococcal Disease Drugs Production by Regions 5.1.2 Global Meningococcal Disease Drugs Revenue by Regions 5.2 Meningococcal Disease Drugs Consumption by Regions 5.3 North America Meningococcal Disease Drugs Market Analysis 5.3.1 North America Meningococcal Disease Drugs Production 5.3.2 North America Meningococcal Disease Drugs Revenue 5.3.3 Key Manufacturers in North America 5.3.4 North America Meningococcal Disease Drugs Import and Export 5.4 Europe Meningococcal Disease Drugs Market Analysis 5.4.1 Europe Meningococcal Disease Drugs Production 5.4.2 Europe Meningococcal Disease Drugs Revenue 5.4.3 Key Manufacturers in Europe 5.4.4 Europe Meningococcal Disease Drugs Import and Export 5.5 China Meningococcal Disease Drugs Market Analysis 5.5.1 China Meningococcal Disease Drugs Production 5.5.2 China Meningococcal Disease Drugs Revenue 5.5.3 Key Manufacturers in China 5.5.4 China Meningococcal Disease Drugs Import and Export 5.6 Japan Meningococcal Disease Drugs Market Analysis 5.6.1 Japan Meningococcal Disease Drugs Production 5.6.2 Japan Meningococcal Disease Drugs Revenue 5.6.3 Key Manufacturers in Japan 5.6.4 Japan Meningococcal Disease Drugs Import and Export 5.7 Southeast Asia Meningococcal Disease Drugs Market Analysis 5.7.1 Southeast Asia Meningococcal Disease Drugs Production 5.7.2 Southeast Asia Meningococcal Disease Drugs Revenue 5.7.3 Key Manufacturers in Southeast Asia 5.7.4 Southeast Asia Meningococcal Disease Drugs Import and Export 5.8 India Meningococcal Disease Drugs Market Analysis 5.8.1 India Meningococcal Disease Drugs Production 5.8.2 India Meningococcal Disease Drugs Revenue 5.8.3 Key Manufacturers in India 5.8.4 India Meningococcal Disease Drugs Import and Export 6 Meningococcal Disease Drugs Segment Market Analysis (by Type) 6.1 Global Meningococcal Disease Drugs Production by Type 6.2 Global Meningococcal Disease Drugs Revenue by Type 6.3 Meningococcal Disease Drugs Price by Type 7 Meningococcal Disease Drugs Segment Market Analysis (by Application) 7.1 Global Meningococcal Disease Drugs Consumption by Application 7.2 Global Meningococcal Disease Drugs Consumption Market Share by Application (2014-2019) 8 Meningococcal Disease Drugs Major Manufacturers Analysis 8.1 Pfizer 8.1.1 Pfizer Meningococcal Disease Drugs Production Sites and Area Served 8.1.2 Pfizer Product Introduction, Application and Specification 8.1.3 Pfizer Meningococcal Disease Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019) 8.1.4 Main Business and Markets Served 8.2 GlaxoSmithKline 8.2.1 GlaxoSmithKline Meningococcal Disease Drugs Production Sites and Area Served 8.2.2 GlaxoSmithKline Product Introduction, Application and Specification 8.2.3 GlaxoSmithKline Meningococcal Disease Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019) 8.2.4 Main Business and Markets Served 8.3 Sanofi Pasteur 8.3.1 Sanofi Pasteur Meningococcal Disease Drugs Production Sites and Area Served 8.3.2 Sanofi Pasteur Product Introduction, Application and Specification 8.3.3 Sanofi Pasteur Meningococcal Disease Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019) 8.3.4 Main Business and Markets Served 8.4 Novartis  8.4.1 Novartis  Meningococcal Disease Drugs Production Sites and Area Served 8.4.2 Novartis  Product Introduction, Application and Specification 8.4.3 Novartis  Meningococcal Disease Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019) 8.4.4 Main Business and Markets Served 9 Development Trend of Analysis of Meningococcal Disease Drugs Market 9.1 Global Meningococcal Disease Drugs Market Trend Analysis 9.1.1 Global Meningococcal Disease Drugs Market Size (Volume and Value) Forecast 2019-2025 9.2 Meningococcal Disease Drugs Regional Market Trend 9.2.1 North America Meningococcal Disease Drugs Forecast 2019-2025 9.2.2 Europe Meningococcal Disease Drugs Forecast 2019-2025 9.2.3 China Meningococcal Disease Drugs Forecast 2019-2025 9.2.4 Japan Meningococcal Disease Drugs Forecast 2019-2025 9.2.5 Southeast Asia Meningococcal Disease Drugs Forecast 2019-2025 9.2.6 India Meningococcal Disease Drugs Forecast 2019-2025 9.3 Meningococcal Disease Drugs Market Trend (Product Type) 9.4 Meningococcal Disease Drugs Market Trend (Application) 10.1 Marketing Channel 10.1.1 Direct Marketing 10.1.2 Indirect Marketing 10.3 Meningococcal Disease Drugs Customers 11 Market Dynamics 11.1 Market Trends 11.2 Opportunities 11.3 Market Drivers 11.4 Challenges 11.5 Influence Factors 12 Conclusion 13 Appendix 13.1 Methodology/Research Approach 13.1.1 Research Programs/Design 13.1.2 Market Size Estimation 13.1.3 Market Breakdown and Data Triangulation 13.2 Data Source 13.2.1 Secondary Sources 13.2.2 Primary Sources 13.3 Author List 13.4 Disclaimer

List of Tables and Figures Figure Picture of Meningococcal Disease Drugs Table Global Meningococcal Disease Drugs Production (K Units) Growth Rate Comparison by Types (2014-2025) Figure Global Meningococcal Disease Drugs Production Market Share by Types in 2018 Figure Injectable Product Picture Figure Oral Product Picture Table Global Meningococcal Disease Drugs Consumption (K Units) Comparison by Applications (2014-2025) Figure Global Meningococcal Disease Drugs Consumption Market Share by Applications in 2018 Figure Hospitals Figure Drugstores Figure Others Figure Global Meningococcal Disease Drugs Revenue (Million USD) (2014-2025) Figure Global Meningococcal Disease Drugs Production (K Units) (2014-2025) Figure North America Meningococcal Disease Drugs Market Size (Million USD) (2014-2025) Figure Europe Meningococcal Disease Drugs Market Size (Million USD) (2014-2025) Figure China Meningococcal Disease Drugs Market Size (Million USD) (2014-2025) Figure Japan Meningococcal Disease Drugs Market Size (Million USD) (2014-2025) Figure Southeast Asia Meningococcal Disease Drugs Market Size (Million USD) (2014-2025) Figure India Meningococcal Disease Drugs Market Size (Million USD) (2014-2025) Table Meningococcal Disease Drugs Raw Material and Suppliers Table Manufacturing Cost Structure Analysis of Meningococcal Disease Drugs in 2018 Figure Manufacturing Process Analysis of Meningococcal Disease Drugs Figure Industry Chain Structure of Meningococcal Disease Drugs Table Capacity and Commercial Production Date of Key Manufacturers Table Global Meningococcal Disease Drugs Manufacturing Plants Distribution Table Meningococcal Disease Drugs Major Manufacturers Technology Source and Market Position Table Recent Development and Expansion Plans in Future Table Meningococcal Disease Drugs Capacity (K Units) of Major Manufacturers (2014-2019) Table Meningococcal Disease Drugs Production (K Units) of Major Manufacturers (2014-2019) Table Meningococcal Disease Drugs Production Market Share of Major Manufacturers (2014-2019) Figure Meningococcal Disease Drugs Production Share by Manufacturers in 2018 Table Meningococcal Disease Drugs Revenue (Million US$) of Major Manufacturers (2014-2019) Table Meningococcal Disease Drugs Revenue Market Share of Major Manufacturers (2014-2019) Figure Meningococcal Disease Drugs Revenue Share by Manufacturers in 2018 Table Meningococcal Disease Drugs Average Price (USD/Unit) of Major Manufacturers (2014-2019) Table Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table Global Meningococcal Disease Drugs Production by Regions 2014-2019 (K Units) Table Global Meningococcal Disease Drugs Production Market Share by Regions 2014-2019 Figure Global Meningococcal Disease Drugs Production Market Share by Regions in 2018 Table Global Meningococcal Disease Drugs Revenue by Regions 2014-2019 (Million USD) Table Global Meningococcal Disease Drugs Revenue Market Share by Regions 2014-2019 Figure Global Meningococcal Disease Drugs Revenue Market Share by Regions in 2018 Table Global Meningococcal Disease Drugs Consumption by Regions 2014-2019 (K Units) Table Global Meningococcal Disease Drugs Consumption Market Share by Regions 2014-2019 Figure North America Meningococcal Disease Drugs Production Growth Rate 2014-2019 (K Units) Figure North America Meningococcal Disease Drugs Revenue Growth Rate 2014-2019 (Million USD) Table North America Meningococcal Disease Drugs Production, Consumption Import and Export (K Units) Figure Europe Meningococcal Disease Drugs Production Growth Rate 2014-2019 (K Units) Figure Europe Meningococcal Disease Drugs Revenue Growth Rate 2014-2019 (Million USD) Table Europe Meningococcal Disease Drugs Production, Consumption Import and Export (K Units) Figure China Meningococcal Disease Drugs Production Growth Rate 2014-2019 (K Units) Figure China Meningococcal Disease Drugs Revenue Growth Rate 2014-2019 (Million USD) Table China Meningococcal Disease Drugs Production, Consumption Import and Export (K Units) Figure Japan Meningococcal Disease Drugs Production Growth Rate 2014-2019 (K Units) Figure Japan Meningococcal Disease Drugs Revenue Growth Rate 2014-2019 (Million USD) Table Japan Meningococcal Disease Drugs Production, Consumption Import and Export (K Units) Figure Southeast Asia Meningococcal Disease Drugs Production Growth Rate 2014-2019 (K Units) Figure Southeast Asia Meningococcal Disease Drugs Revenue Growth Rate 2014-2019 (Million USD) Table Southeast Asia Meningococcal Disease Drugs Production, Consumption Import and Export (K Units) Figure India Meningococcal Disease Drugs Production Growth Rate 2014-2019 (K Units) Figure India Meningococcal Disease Drugs Revenue Growth Rate 2014-2019 (Million USD) Table India Meningococcal Disease Drugs Production, Consumption Import and Export (K Units) Figure Global Consumption Meningococcal Disease Drugs Market Share by Application (2014-2019) Figure Global Value (Consumption) Meningococcal Disease Drugs Market Share by Application (2014-2019) Table Pfizer Meningococcal Disease Drugs Production Sites and Area Served Table Pfizer Meningococcal Disease Drugs Product Introduction, Application and Specification Table Pfizer Meningococcal Disease Drugs Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019) Table Pfizer Meningococcal Disease Drugs Production Growth Rate (2014-2019) Table Pfizer Meningococcal Disease Drugs Production Market Share (2014-2019) Figure Pfizer Meningococcal Disease Drugs Revenue Market Share (2014-2019) Table Pfizer Meningococcal Disease Drugs Main Business and Markets Served Table GlaxoSmithKline Meningococcal Disease Drugs Production Sites and Area Served Table GlaxoSmithKline Meningococcal Disease Drugs Product Introduction, Application and Specification Table GlaxoSmithKline Meningococcal Disease Drugs Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019) Table GlaxoSmithKline Meningococcal Disease Drugs Production Growth Rate (2014-2019) Table GlaxoSmithKline Meningococcal Disease Drugs Production Market Share (2014-2019) Figure GlaxoSmithKline Meningococcal Disease Drugs Revenue Market Share (2014-2019) Table GlaxoSmithKline Meningococcal Disease Drugs Main Business and Markets Served Table Sanofi Pasteur Meningococcal Disease Drugs Production Sites and Area Served Table Sanofi Pasteur Meningococcal Disease Drugs Product Introduction, Application and Specification Table Sanofi Pasteur Meningococcal Disease Drugs Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019) Table Sanofi Pasteur Meningococcal Disease Drugs Production Growth Rate (2014-2019) Table Sanofi Pasteur Meningococcal Disease Drugs Production Market Share (2014-2019) Figure Sanofi Pasteur Meningococcal Disease Drugs Revenue Market Share (2014-2019) Table Sanofi Pasteur Meningococcal Disease Drugs Main Business and Markets Served Table Novartis  Meningococcal Disease Drugs Production Sites and Area Served Table Novartis  Meningococcal Disease Drugs Product Introduction, Application and Specification Table Novartis  Meningococcal Disease Drugs Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019) Table Novartis  Meningococcal Disease Drugs Production Growth Rate (2014-2019) Table Novartis  Meningococcal Disease Drugs Production Market Share (2014-2019) Figure Novartis  Meningococcal Disease Drugs Revenue Market Share (2014-2019) Table Novartis  Meningococcal Disease Drugs Main Business and Markets Served Figure Global Meningococcal Disease Drugs Production (K Units) Growth Rate Forecast 2019-2025 Figure Global Meningococcal Disease Drugs Revenue (Million USD) Growth Rate Forecast 2019-2025 Figure Global Meningococcal Disease Drugs Sales Price (USD/Unit) Forecast 2019-2025 Figure North America Meningococcal Disease Drugs Production Growth Rate Forecast 2019-2025 (K Units) Figure North America Meningococcal Disease Drugs Revenue Growth Rate Forecast 2019-2025 (Million USD) Figure Europe Meningococcal Disease Drugs Production Growth Rate Forecast 2019-2025 (K Units) Figure Europe Meningococcal Disease Drugs Revenue Growth Rate Forecast 2019-2025 (Million USD) Figure China Meningococcal Disease Drugs Production Growth Rate Forecast 2019-2025 (K Units) Figure China Meningococcal Disease Drugs Revenue Growth Rate Forecast 2019-2025 (Million USD) Figure Japan Meningococcal Disease Drugs Production Growth Rate Forecast 2019-2025 (K Units) Figure Japan Meningococcal Disease Drugs Revenue Growth Rate Forecast 2019-2025 (Million USD) Figure Southeast Asia Meningococcal Disease Drugs Production Growth Rate Forecast 2019-2025 (K Units) Figure Southeast Asia Meningococcal Disease Drugs Revenue Growth Rate Forecast 2019-2025 (Million USD) Figure India Meningococcal Disease Drugs Production Growth Rate Forecast 2019-2025 (K Units) Figure India Meningococcal Disease Drugs Revenue Growth Rate Forecast 2019-2025 (Million USD) Table Global Production (K Units) of Meningococcal Disease Drugs by Type (2019-2025) Table Global Consumption (K Units) of Meningococcal Disease Drugs by Application (2019-2025) Table Meningococcal Disease Drugs Distributors List Table Meningococcal Disease Drugs Customers List Table Market Key Trends Table Key Opportunities Table Market Key Drivers Table Key Challenges Table Key Influence Factors Table Research Programs/Design for This Report Figure Bottom-up and Top-down Approaches for This Report Figure Data Triangulation Table Key Data Information from Secondary Sources Table Key Data Information from Primary Sources

Pfizer GlaxoSmithKline Sanofi Pasteur Novartis